Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China.
Kaifeng Municipal Key Laboratory of Cell Signal Transduction, Henan Provincial Engineering Centre for Tumor Molecular Medicine, Henan University, Kaifeng, Henan, China.
J Appl Microbiol. 2021 Nov;131(5):2131-2147. doi: 10.1111/jam.15036. Epub 2021 Mar 6.
Obesity is considered as a risk factor for chronic health diseases such as heart diseases, cancer and diabetes 2. Reduced physical activities, lifestyle, poor nutritional diet and genetics are among the risk factors associated with the development of obesity. In recent years, several studies have explored the link between the gut microbiome and the progression of diseases including obesity, with the shift in microbiome abundance and composition being the main focus. The alteration of gut microbiome composition affects both nutrients metabolism and specific gene expressions, thereby disturbing body physiology. Specifically, the abundance of fibre-metabolizing microbes is associated with weight loss and that of protein and fat-metabolizing bacteria with weight gain. Various internal and external factors such as genetics, maternal obesity, mode of delivery, breastfeeding, nutrition, antibiotic use and the chemical compounds present in the environment are known to interfere with the richness of the gut microbiota (GM), thus influencing weight gain/loss and ultimately the development of obesity. However, the effectiveness of each factor in potentiating the shift in microbes' abundance to result in significant changes that can lead to obesity is not yet clear. In this review, we will highlight the factors involved in shaping GM, their influence on obesity and possible interventions. Understanding the influence of these factors on the diversity of the GM and how to improve their effectiveness on disease conditions could be keys in the treatment of metabolic diseases.
肥胖被认为是心脏病、癌症和糖尿病等慢性健康疾病的一个风险因素。2 减少体力活动、生活方式、不良营养饮食和遗传是与肥胖发展相关的风险因素之一。近年来,许多研究探索了肠道微生物组与包括肥胖在内的疾病进展之间的联系,主要关注微生物组丰度和组成的变化。肠道微生物组组成的改变会影响营养物质的代谢和特定基因的表达,从而扰乱身体的生理机能。具体来说,纤维代谢微生物的丰度与体重减轻有关,而蛋白质和脂肪代谢细菌的丰度与体重增加有关。已知许多内部和外部因素,如遗传、母亲肥胖、分娩方式、母乳喂养、营养、抗生素使用和环境中存在的化学物质,会干扰肠道微生物群(GM)的丰富度,从而影响体重增减,最终导致肥胖。然而,每个因素在增强微生物丰度变化以导致可能导致肥胖的显著变化方面的有效性尚不清楚。在这篇综述中,我们将重点介绍影响 GM 的因素、它们对肥胖的影响以及可能的干预措施。了解这些因素对 GM 多样性的影响,以及如何提高它们在疾病情况下的有效性,可能是治疗代谢性疾病的关键。